In 2022, the World Health Organization (WHO) updated its guidelines for treating drug-resistant tuberculosis (DR-TB), recommending a six-month cure.

This guide lays out what activists need to know about the new DR-TB treatment regimens, including an overview of findings from the trials that underpin the updated WHO guidelines and important considerations for key populations affected by TB. It is intended to equip advocates with information they need to formulate arguments and push for universal implementation of the best available treatments.